Indication
Complicated UTI
7 clinical trials
13 products
Clinical trial
Single Group Phase 2 Study to Investigate Pharmacokinetics, Safety and Tolerability of Cefepime-Enmetazobactam Administered by IV Over 2 Hr in Male or Female Participants From Birth to Less Than 18 Years of Age Hospitalised With cUTIStatus: Recruiting, Estimated PCD: 2025-09-30
Product
Cefepime + EnmetazobactamClinical trial
A Phase 3, Randomized, Double-blind, Multicenter, Comparative Study to Determine the Efficacy and Safety of Cefepime-zidebactam vs. Meropenem in the Treatment of Complicated Urinary Tract Infection or Acute Pyelonephritis in AdultsStatus: Recruiting, Estimated PCD: 2024-04-01
Product
Cefepime-zidebactamProduct
MeropenemProduct
Cefepime + NacubactamProduct
Aztreonam + NacubactamProduct
imipenem/cilastatinClinical trial
A Phase 3, Multi-Center, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in the Treatment of Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis, in AdultsStatus: Recruiting, Estimated PCD: 2024-08-01
Product
WCK 4282Clinical trial
A Phase III, Randomized, Double-Blind, Multicenter, Comparative Study to Determine the Efficacy and Safety of Cefepime-Tazobactam vs. Meropenem Followed by Optional Oral Therapy in the Treatment of Complicated Urinary Tract Infection or Acute Pyelonephritis in AdultsStatus: Not yet recruiting, Estimated PCD: 2026-01-01
Product
CiprofloxacinClinical trial
Expanded Access for the Use of Sulopenem Etzadroxil/Probenecid for the Treatment of Patients With Complicated Urinary Tract Infection Due to Quinolone-nonsusceptible UropathogensStatus:
Product
SulopenemProduct
Ceftolozane/TazobactamClinical trial
A Phase 2, Randomized, Active Comparator-Controlled, Multicenter, Double-Blind Clinical Trial to Study the Safety and Efficacy of Ceftolozane/Tazobactam (MK-7625A) Versus Meropenem in Pediatric Subjects With Complicated Urinary Tract Infection, Including PyelonephritisStatus: Completed, Estimated PCD: 2020-12-03
Clinical trial
CHOICE UTI - Clinical Efficacy of Single Dose (Daily) IV Antibiotics Followed by 2 Days Oral Antibiotics Compared to 3 Doses (Daily) IV Antibiotics for Children With Complicated Urinary Tract Infections: a Multicentre Randomised TrialStatus: Recruiting, Estimated PCD: 2028-05-16
Product
BenzylpenicillinProduct
GentamicinProduct
Cefalexin